In this Medilink Midlands webinar, the Office for Life Sciences, the Government’s specialist team that sponsors the sector, will present on everything firms developing, manufacturing and selling Medicines need to know about the end of the Transition Period, and what will happen next.
In particular, they will cover:
– The latest on Trade Negotiations with the European Union, as well as the United States and Australia
– How the regulation of Medicines is changing from the 1 January, what your business needs to get ready, and how the UK will develop a new sovereign system
– How the border, imports and exports will work from 1 January; and
– Action that firms need to take on Data, Immigration and Global Recruitment, and EU research funding
The session will include plenty of time for questions, as well as guidance on where to go for further information, support and advice.
Please note – this webinar will cover similar material to the webinars run by Medilink Midlands and the Office for Life Sciences on 4 and 23 November.
Dr Robert Reid, Head of Medicines Regulation and Engagement, Office for Life Sciences
Robert works in the Office for Life Sciences, where he is responsible for Medicines Regulation and Business Readiness for the end of the Transition Period. Rob holds a PhD in Molecular Biology from the University of Leicester, and previously worked at the National Physical Laboratory and Which?
Elspeth Bailey, Policy Advisor, Office for Life Sciences
Elspeth works in the Office for Life Sciences, where she leads on the Northern Ireland Protocol and supports work on Business Readiness for the end of the Transition Period. Previously, Elspeth has taught in China, and worked in the Government team responsible for the Aerospace Sector.